April, 2024
April 2024
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Sabine Brookman-May: TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR
Feb 21, 2024, 18:28

Sabine Brookman-May: TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR

Sabine Brookman-May, Professor of Urology at the Ludwig-Maximilians University of Munchen, posted on X/Twitter:

Finally out: results of the legacy phase 1b study which built the groundwork for our ongoing phase 2 + 3 studies with the intravesical gemcitabine releasing system TAR-200.

TAR-200 was safe and well tolerated, with encouraging preliminary efficacy in IR.”

Image

Image

Source: Sabine Brookman-May/X